Vol 1, No 4 (December 13, 2012): Translational Lung Cancer Research

Editorials

Intrapulmonary lymph node retrieval: unclear benefit for aggressive pathologic dissection

Christina Brzezniak, Giuseppe Giaccone

PDF Pages: 230-233 Full Text (6635) Open Access

Gene therapy for lung cancer malignant pleural effusion: current and future nano-biotechnology

Paul Zarogoulidis, Kalliopi Domvri, Haidong Huang, Konstantinos Zarogoulidis

PDF Pages: 234-237 Full Text (3168) Open Access

Review Articles

MET inhibitors in combination with other therapies in non-small cell lung cancer

Sukhmani Padda, Joel W. Neal, Heather A. Wakelee

PDF Pages: 238-253 Full Text (11035) Open Access

Potential toxicities of prophylactic cranial irradiation

Frank A. Giordano, Grit Welzel, Yasser Abo-Madyan, Frederik Wenz

PDF Pages: 254-262 Full Text (18753) Open Access

Innovative technologies in thoracic radiation therapy for lung cancer

Andrea Riccardo Filippi, Cristina Mantovani, Umberto Ricardi

PDF Pages: 263-268 Full Text (4168) Open Access

EGFR-directed monoclonal antibodies in non-small cell lung cancer: how to predict efficacy?

Robert Pirker

PDF Pages: 269-275 Full Text (6108) Open Access

Perspective

Pulmonary adenocarcinoma histology

Erik Thunnissen

PDF Pages: 276-279 Full Text (7165) Open Access

EGFR TKIs¹

Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer

Antonio Passaro, Enrico Cortesi

PDF Pages: 280-282 Full Text (3344) Open Access

The TORCH trial

Louise Rosalyn Carter, Raffaele Califano

PDF Pages: 283-286 Full Text (4563) Open Access

Expanding options for EGFR targeting in lung cancer

Tina Chou, Richard S. Finn, Edward B Garon

PDF Pages: 287-288 Full Text (2947) Open Access

Case Report

Spontaneous bilateral pneumothorax in a patient with metastatic synovial sarcoma while under chemotherapy

Mohammed Sadeq Ahmed

PDF Pages: 289-291 Full Text (3356) Open Access

Disclosure:

1. The series “EGFR TKIs” was commissioned by the Editorial office, Translational Lung Cancer Research without any sponsorship or funding.